ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glucokinase Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-16M7240
Home | Market Reports | Food & Drink
Global Glucokinase Market Insights Forecast to 2028
BUY CHAPTERS

Global Glucokinase Market Research Report 2024

Code: QYRE-Auto-16M7240
Report
August 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals, Inc.
Merck& Co. Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp

Glucokinase Market

The global Glucokinase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glucokinase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucokinase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glucokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucokinase.

Report Scope

The Glucokinase market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucokinase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Glucokinase Market Report

Report Metric Details
Report Name Glucokinase Market
Segment by Type
  • LY-2608204
  • Sinogliatin
  • AM-9514
  • TMG-123
  • TTP-399
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc, Yuhan Corp
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Glucokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Glucokinase Market report?

Ans: The main players in the Glucokinase Market are Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc, Yuhan Corp

What are the Application segmentation covered in the Glucokinase Market report?

Ans: The Applications covered in the Glucokinase Market report are Metabolic Disorder, Obesity, Diabetes, Others

What are the Type segmentation covered in the Glucokinase Market report?

Ans: The Types covered in the Glucokinase Market report are LY-2608204, Sinogliatin, AM-9514, TMG-123, TTP-399, Others

Recommended Reports

Diabetes & Insulin

Antidiabetics & Sweeteners

Metabolic & Drug Testing

1 Glucokinase Market Overview
1.1 Product Overview and Scope of Glucokinase
1.2 Glucokinase Segment by Type
1.2.1 Global Glucokinase Market Value Comparison by Type (2024-2030)
1.2.2 LY-2608204
1.2.3 Sinogliatin
1.2.4 AM-9514
1.2.5 TMG-123
1.2.6 TTP-399
1.2.7 Others
1.3 Glucokinase Segment by Application
1.3.1 Global Glucokinase Market Value by Application: (2024-2030)
1.3.2 Metabolic Disorder
1.3.3 Obesity
1.3.4 Diabetes
1.3.5 Others
1.4 Global Glucokinase Market Size Estimates and Forecasts
1.4.1 Global Glucokinase Revenue 2019-2030
1.4.2 Global Glucokinase Sales 2019-2030
1.4.3 Global Glucokinase Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucokinase Market Competition by Manufacturers
2.1 Global Glucokinase Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucokinase Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucokinase Average Price by Manufacturers (2019-2024)
2.4 Global Glucokinase Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucokinase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucokinase, Product Type & Application
2.7 Glucokinase Market Competitive Situation and Trends
2.7.1 Glucokinase Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucokinase Players Market Share by Revenue
2.7.3 Global Glucokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucokinase Retrospective Market Scenario by Region
3.1 Global Glucokinase Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucokinase Global Glucokinase Sales by Region: 2019-2030
3.2.1 Global Glucokinase Sales by Region: 2019-2024
3.2.2 Global Glucokinase Sales by Region: 2025-2030
3.3 Global Glucokinase Global Glucokinase Revenue by Region: 2019-2030
3.3.1 Global Glucokinase Revenue by Region: 2019-2024
3.3.2 Global Glucokinase Revenue by Region: 2025-2030
3.4 North America Glucokinase Market Facts & Figures by Country
3.4.1 North America Glucokinase Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucokinase Sales by Country (2019-2030)
3.4.3 North America Glucokinase Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucokinase Market Facts & Figures by Country
3.5.1 Europe Glucokinase Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucokinase Sales by Country (2019-2030)
3.5.3 Europe Glucokinase Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucokinase Market Facts & Figures by Country
3.6.1 Asia Pacific Glucokinase Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucokinase Sales by Country (2019-2030)
3.6.3 Asia Pacific Glucokinase Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glucokinase Market Facts & Figures by Country
3.7.1 Latin America Glucokinase Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucokinase Sales by Country (2019-2030)
3.7.3 Latin America Glucokinase Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucokinase Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucokinase Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucokinase Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucokinase Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucokinase Sales by Type (2019-2030)
4.1.1 Global Glucokinase Sales by Type (2019-2024)
4.1.2 Global Glucokinase Sales by Type (2025-2030)
4.1.3 Global Glucokinase Sales Market Share by Type (2019-2030)
4.2 Global Glucokinase Revenue by Type (2019-2030)
4.2.1 Global Glucokinase Revenue by Type (2019-2024)
4.2.2 Global Glucokinase Revenue by Type (2025-2030)
4.2.3 Global Glucokinase Revenue Market Share by Type (2019-2030)
4.3 Global Glucokinase Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucokinase Sales by Application (2019-2030)
5.1.1 Global Glucokinase Sales by Application (2019-2024)
5.1.2 Global Glucokinase Sales by Application (2025-2030)
5.1.3 Global Glucokinase Sales Market Share by Application (2019-2030)
5.2 Global Glucokinase Revenue by Application (2019-2030)
5.2.1 Global Glucokinase Revenue by Application (2019-2024)
5.2.2 Global Glucokinase Revenue by Application (2025-2030)
5.2.3 Global Glucokinase Revenue Market Share by Application (2019-2030)
5.3 Global Glucokinase Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen Inc
6.1.1 Amgen Inc Corporation Information
6.1.2 Amgen Inc Description and Business Overview
6.1.3 Amgen Inc Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Inc Glucokinase Product Portfolio
6.1.5 Amgen Inc Recent Developments/Updates
6.2 Eli Lilly and Co
6.2.1 Eli Lilly and Co Corporation Information
6.2.2 Eli Lilly and Co Description and Business Overview
6.2.3 Eli Lilly and Co Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly and Co Glucokinase Product Portfolio
6.2.5 Eli Lilly and Co Recent Developments/Updates
6.3 Ligand Pharmaceuticals Inc
6.3.1 Ligand Pharmaceuticals Inc Corporation Information
6.3.2 Ligand Pharmaceuticals Inc Description and Business Overview
6.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
6.3.5 Ligand Pharmaceuticals Inc Recent Developments/Updates
6.4 Merck & Co Inc
6.4.1 Merck & Co Inc Corporation Information
6.4.2 Merck & Co Inc Description and Business Overview
6.4.3 Merck & Co Inc Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co Inc Glucokinase Product Portfolio
6.4.5 Merck & Co Inc Recent Developments/Updates
6.5 Poxel SA
6.5.1 Poxel SA Corporation Information
6.5.2 Poxel SA Description and Business Overview
6.5.3 Poxel SA Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Poxel SA Glucokinase Product Portfolio
6.5.5 Poxel SA Recent Developments/Updates
6.6 Teijin Pharma Ltd
6.6.1 Teijin Pharma Ltd Corporation Information
6.6.2 Teijin Pharma Ltd Description and Business Overview
6.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
6.6.5 Teijin Pharma Ltd Recent Developments/Updates
6.7 vTv Therapeutics Inc
6.6.1 vTv Therapeutics Inc Corporation Information
6.6.2 vTv Therapeutics Inc Description and Business Overview
6.6.3 vTv Therapeutics Inc Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.4.4 vTv Therapeutics Inc Glucokinase Product Portfolio
6.7.5 vTv Therapeutics Inc Recent Developments/Updates
6.8 Yuhan Corp
6.8.1 Yuhan Corp Corporation Information
6.8.2 Yuhan Corp Description and Business Overview
6.8.3 Yuhan Corp Glucokinase Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yuhan Corp Glucokinase Product Portfolio
6.8.5 Yuhan Corp Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucokinase Industry Chain Analysis
7.2 Glucokinase Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucokinase Production Mode & Process
7.4 Glucokinase Sales and Marketing
7.4.1 Glucokinase Sales Channels
7.4.2 Glucokinase Distributors
7.5 Glucokinase Customers
8 Glucokinase Market Dynamics
8.1 Glucokinase Industry Trends
8.2 Glucokinase Market Drivers
8.3 Glucokinase Market Challenges
8.4 Glucokinase Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals, Inc.
Merck& Co. Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp
List of Tables
    Table 1. Global Glucokinase Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Glucokinase Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Glucokinase Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Glucokinase Sales (K Pcs) of Key Manufacturers (2019-2024)
    Table 5. Global Glucokinase Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Glucokinase Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Glucokinase Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Glucokinase Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Glucokinase, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Glucokinase, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Glucokinase, Product Type & Application
    Table 12. Global Key Manufacturers of Glucokinase, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Glucokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucokinase as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Glucokinase Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Glucokinase Sales by Region (2019-2024) & (K Pcs)
    Table 18. Global Glucokinase Sales Market Share by Region (2019-2024)
    Table 19. Global Glucokinase Sales by Region (2025-2030) & (K Pcs)
    Table 20. Global Glucokinase Sales Market Share by Region (2025-2030)
    Table 21. Global Glucokinase Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Glucokinase Revenue Market Share by Region (2019-2024)
    Table 23. Global Glucokinase Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Glucokinase Revenue Market Share by Region (2025-2030)
    Table 25. North America Glucokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Glucokinase Sales by Country (2019-2024) & (K Pcs)
    Table 27. North America Glucokinase Sales by Country (2025-2030) & (K Pcs)
    Table 28. North America Glucokinase Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Glucokinase Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Glucokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Glucokinase Sales by Country (2019-2024) & (K Pcs)
    Table 32. Europe Glucokinase Sales by Country (2025-2030) & (K Pcs)
    Table 33. Europe Glucokinase Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Glucokinase Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Glucokinase Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Glucokinase Sales by Region (2019-2024) & (K Pcs)
    Table 37. Asia Pacific Glucokinase Sales by Region (2025-2030) & (K Pcs)
    Table 38. Asia Pacific Glucokinase Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Glucokinase Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Glucokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Glucokinase Sales by Country (2019-2024) & (K Pcs)
    Table 42. Latin America Glucokinase Sales by Country (2025-2030) & (K Pcs)
    Table 43. Latin America Glucokinase Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Glucokinase Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Glucokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Glucokinase Sales by Country (2019-2024) & (K Pcs)
    Table 47. Middle East & Africa Glucokinase Sales by Country (2025-2030) & (K Pcs)
    Table 48. Middle East & Africa Glucokinase Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Glucokinase Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Glucokinase Sales (K Pcs) by Type (2019-2024)
    Table 51. Global Glucokinase Sales (K Pcs) by Type (2025-2030)
    Table 52. Global Glucokinase Sales Market Share by Type (2019-2024)
    Table 53. Global Glucokinase Sales Market Share by Type (2025-2030)
    Table 54. Global Glucokinase Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Glucokinase Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Glucokinase Revenue Market Share by Type (2019-2024)
    Table 57. Global Glucokinase Revenue Market Share by Type (2025-2030)
    Table 58. Global Glucokinase Price (USD/Pcs) by Type (2019-2024)
    Table 59. Global Glucokinase Price (USD/Pcs) by Type (2025-2030)
    Table 60. Global Glucokinase Sales (K Pcs) by Application (2019-2024)
    Table 61. Global Glucokinase Sales (K Pcs) by Application (2025-2030)
    Table 62. Global Glucokinase Sales Market Share by Application (2019-2024)
    Table 63. Global Glucokinase Sales Market Share by Application (2025-2030)
    Table 64. Global Glucokinase Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Glucokinase Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Glucokinase Revenue Market Share by Application (2019-2024)
    Table 67. Global Glucokinase Revenue Market Share by Application (2025-2030)
    Table 68. Global Glucokinase Price (USD/Pcs) by Application (2019-2024)
    Table 69. Global Glucokinase Price (USD/Pcs) by Application (2025-2030)
    Table 70. Amgen Inc Corporation Information
    Table 71. Amgen Inc Description and Business Overview
    Table 72. Amgen Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 73. Amgen Inc Glucokinase Product
    Table 74. Amgen Inc Recent Developments/Updates
    Table 75. Eli Lilly and Co Corporation Information
    Table 76. Eli Lilly and Co Description and Business Overview
    Table 77. Eli Lilly and Co Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 78. Eli Lilly and Co Glucokinase Product
    Table 79. Eli Lilly and Co Recent Developments/Updates
    Table 80. Ligand Pharmaceuticals Inc Corporation Information
    Table 81. Ligand Pharmaceuticals Inc Description and Business Overview
    Table 82. Ligand Pharmaceuticals Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 83. Ligand Pharmaceuticals Inc Glucokinase Product
    Table 84. Ligand Pharmaceuticals Inc Recent Developments/Updates
    Table 85. Merck & Co Inc Corporation Information
    Table 86. Merck & Co Inc Description and Business Overview
    Table 87. Merck & Co Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 88. Merck & Co Inc Glucokinase Product
    Table 89. Merck & Co Inc Recent Developments/Updates
    Table 90. Poxel SA Corporation Information
    Table 91. Poxel SA Description and Business Overview
    Table 92. Poxel SA Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 93. Poxel SA Glucokinase Product
    Table 94. Poxel SA Recent Developments/Updates
    Table 95. Teijin Pharma Ltd Corporation Information
    Table 96. Teijin Pharma Ltd Description and Business Overview
    Table 97. Teijin Pharma Ltd Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 98. Teijin Pharma Ltd Glucokinase Product
    Table 99. Teijin Pharma Ltd Recent Developments/Updates
    Table 100. vTv Therapeutics Inc Corporation Information
    Table 101. vTv Therapeutics Inc Description and Business Overview
    Table 102. vTv Therapeutics Inc Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 103. vTv Therapeutics Inc Glucokinase Product
    Table 104. vTv Therapeutics Inc Recent Developments/Updates
    Table 105. Yuhan Corp Corporation Information
    Table 106. Yuhan Corp Description and Business Overview
    Table 107. Yuhan Corp Glucokinase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 108. Yuhan Corp Glucokinase Product
    Table 109. Yuhan Corp Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Glucokinase Distributors List
    Table 113. Glucokinase Customers List
    Table 114. Glucokinase Market Trends
    Table 115. Glucokinase Market Drivers
    Table 116. Glucokinase Market Challenges
    Table 117. Glucokinase Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Glucokinase
    Figure 2. Global Glucokinase Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Glucokinase Market Share by Type in 2023 & 2030
    Figure 4. LY-2608204 Product Picture
    Figure 5. Sinogliatin Product Picture
    Figure 6. AM-9514 Product Picture
    Figure 7. TMG-123 Product Picture
    Figure 8. TTP-399 Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Glucokinase Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Glucokinase Market Share by Application in 2023 & 2030
    Figure 12. Metabolic Disorder
    Figure 13. Obesity
    Figure 14. Diabetes
    Figure 15. Others
    Figure 16. Global Glucokinase Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Glucokinase Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Glucokinase Sales (2019-2030) & (K Pcs)
    Figure 19. Global Glucokinase Average Price (USD/Pcs) & (2019-2030)
    Figure 20. Glucokinase Report Years Considered
    Figure 21. Glucokinase Sales Share by Manufacturers in 2023
    Figure 22. Global Glucokinase Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Glucokinase Players: Market Share by Revenue in 2023
    Figure 24. Glucokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Glucokinase Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Glucokinase Sales Market Share by Country (2019-2030)
    Figure 27. North America Glucokinase Revenue Market Share by Country (2019-2030)
    Figure 28. U.S. Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Glucokinase Sales Market Share by Country (2019-2030)
    Figure 31. Europe Glucokinase Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Glucokinase Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Glucokinase Revenue Market Share by Region (2019-2030)
    Figure 39. China Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Taiwan Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Philippines Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Latin America Glucokinase Sales Market Share by Country (2019-2030)
    Figure 50. Latin America Glucokinase Revenue Market Share by Country (2019-2030)
    Figure 51. Mexico Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Brazil Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Argentina Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Middle East & Africa Glucokinase Sales Market Share by Country (2019-2030)
    Figure 55. Middle East & Africa Glucokinase Revenue Market Share by Country (2019-2030)
    Figure 56. Turkey Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. UAE Glucokinase Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 59. Global Sales Market Share of Glucokinase by Type (2019-2030)
    Figure 60. Global Revenue Market Share of Glucokinase by Type (2019-2030)
    Figure 61. Global Glucokinase Price (USD/Pcs) by Type (2019-2030)
    Figure 62. Global Sales Market Share of Glucokinase by Application (2019-2030)
    Figure 63. Global Revenue Market Share of Glucokinase by Application (2019-2030)
    Figure 64. Global Glucokinase Price (USD/Pcs) by Application (2019-2030)
    Figure 65. Glucokinase Value Chain
    Figure 66. Glucokinase Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Glucobay Market Research Report 2024
Global Oral Glucose Market Research Report 2025
Global Liquid Glucose Market Research Report 2025
Global Glycomic Enzyme Market Research Report 2024
Global Diabetes Screening Market Research Report 2024
Global Glucose Management Supplements Market Research Report 2025
Global Glucose Tracking App Market Research Report 2024
Global Glycolide GA Market Research Report 2025
Global Glucose and Fructose Market Research Report 2024
Global Meal Kits Market Research Report 2024
Global Fructose for Pharmaceutical Market Research Report 2025
Global β Glucosidase Market Research Report 2024
Global Blood Sugar Supplements Market Research Report 2025
Global Meal Kits Food Market Research Report 2024
Global Amylases Market Research Report 2025
Global Diet Candy Market Research Report 2024
Global Glucose Oxidase Market Research Report 2024
Global Guanosine Market Research Report 2025
Global Highly Efficient Glucoamylase Market Research Report 2024
Global Food Grade Glucose Market Research Report 2025

RELATED REPORTS

Global Catering Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32L5949
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Wrapping Greaseproof Paper Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20R17639
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Bottle Display Packaging Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22T5904
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global AIP Meal Delivery Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8B16714
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions